Cargando…
EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232813/ http://dx.doi.org/10.1016/j.jval.2022.04.923 |
| _version_ | 1784735679758991360 |
|---|---|
| author | Zhou, D Shao, T Shao, H Tu, Y Tang, Y Zhou, J Malone, DC Tang, W |
| author_facet | Zhou, D Shao, T Shao, H Tu, Y Tang, Y Zhou, J Malone, DC Tang, W |
| author_sort | Zhou, D |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9232813 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92328132022-06-27 EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China Zhou, D Shao, T Shao, H Tu, Y Tang, Y Zhou, J Malone, DC Tang, W Value Health Article Published by Elsevier Inc. 2022-07 2022-06-25 /pmc/articles/PMC9232813/ http://dx.doi.org/10.1016/j.jval.2022.04.923 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Zhou, D Shao, T Shao, H Tu, Y Tang, Y Zhou, J Malone, DC Tang, W EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China |
| title | EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China |
| title_full | EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China |
| title_fullStr | EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China |
| title_full_unstemmed | EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China |
| title_short | EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China |
| title_sort | eph172 when is it valuable for covid-19 booster dose?: a transmission dynamics model-based effectiveness and cost-effectiveness analysis of two booster dose vaccination priority strategies in mainland china |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232813/ http://dx.doi.org/10.1016/j.jval.2022.04.923 |
| work_keys_str_mv | AT zhoud eph172whenisitvaluableforcovid19boosterdoseatransmissiondynamicsmodelbasedeffectivenessandcosteffectivenessanalysisoftwoboosterdosevaccinationprioritystrategiesinmainlandchina AT shaot eph172whenisitvaluableforcovid19boosterdoseatransmissiondynamicsmodelbasedeffectivenessandcosteffectivenessanalysisoftwoboosterdosevaccinationprioritystrategiesinmainlandchina AT shaoh eph172whenisitvaluableforcovid19boosterdoseatransmissiondynamicsmodelbasedeffectivenessandcosteffectivenessanalysisoftwoboosterdosevaccinationprioritystrategiesinmainlandchina AT tuy eph172whenisitvaluableforcovid19boosterdoseatransmissiondynamicsmodelbasedeffectivenessandcosteffectivenessanalysisoftwoboosterdosevaccinationprioritystrategiesinmainlandchina AT tangy eph172whenisitvaluableforcovid19boosterdoseatransmissiondynamicsmodelbasedeffectivenessandcosteffectivenessanalysisoftwoboosterdosevaccinationprioritystrategiesinmainlandchina AT zhouj eph172whenisitvaluableforcovid19boosterdoseatransmissiondynamicsmodelbasedeffectivenessandcosteffectivenessanalysisoftwoboosterdosevaccinationprioritystrategiesinmainlandchina AT malonedc eph172whenisitvaluableforcovid19boosterdoseatransmissiondynamicsmodelbasedeffectivenessandcosteffectivenessanalysisoftwoboosterdosevaccinationprioritystrategiesinmainlandchina AT tangw eph172whenisitvaluableforcovid19boosterdoseatransmissiondynamicsmodelbasedeffectivenessandcosteffectivenessanalysisoftwoboosterdosevaccinationprioritystrategiesinmainlandchina |